Forbidden Drugs 3E:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Oxford
Oxford University Press
c2009
|
| Ausgabe: | 3rd ed |
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Includes bibliographical references and index 1. Why use drugs? -- 2. The consequences of drug use -- 3. Alcohol -- 4. Tobacco -- 5. Cannabis -- 6. Cocaine amphetamines, and other stimulants -- 7. Psychedelics and hallucinogens -- 8. The inhalants -- 9. Ecstasy and other 'party drugs' -- 10. Anabolic steroids -- 11. Tranquillizers and sleeping pills -- 12. Heroin and the opioids -- 13. The nature of addiction -- 14. Helping problem drug users -- 15. International drug policy : is it working? 1. Why use drugs? -- The search for 'altered consciousness' -- Practical reasons for experimenting with drugs -- Biological explanations -- Psychological explanations -- Family and cultural explanations -- Risk taking -- Is experimenting with drugs 'abnormal'? -- 2. The consequences of drug use -- 'Visible' and 'invisible' drug users -- Short-term consequences -- Longer-term consequences -- Influences upon the outcome of dependent drug use -- 3. Alcohol -- Historical background -- Preparation and distribution -- Scientific information -- Possible beneficial effects -- Recreational use -- Unwanted effects -- Acute effects -- Chronic effects -- 4. Tobacco -- Preparation and distribution -- Scientific information -- Possible beneficial effects -- Recreational use -- Unwanted effects -- 5. Cannabis -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- 6. Cocaine amphetamines, and other stimulants -- Cocaine -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Amphetamines -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Other stimulants -- Khat (or Qat) -- Benzylpiperazine -- Pemoline -- Appetite suppressants -- 7. Psychedelics and hallucinogens -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Modern ritualistic use -- Recreational use -- Unwanted effects -- 8. The inhalants -- Historical background -- Preparations available -- Scientific information -- Recreational use -- Unwanted effects -- 9. Ecstasy and other 'party drugs' -- Ecstasy -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Gammahydroxybutyrate (GHB) -- Gamm-butyrolactone (GBL) and 1,4- butanediol (1,4-BD) -- Ketamine -- mCPP -- 10. Anabolic steroids -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- 11. Tranquillizers and sleeping pills -- Barbiturates -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Benzodiazepines -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- 12. Heroin and the opioids -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- 13. The nature of addiction -- Introduction -- Neurobiological mechanisms -- Psychological processes -- Socio-cultural influences -- Issues of personal morality -- Conclusion -- 14. Helping problem drug users -- Drugs and young people -- Psychological treatments : general principles -- Relapse, prevention and rehabilitation -- Self-help groups -- Specific strategies for smokers -- Specific strategies for drinkers -- Specific strategies for opioid users -- Detoxification -- Substitute or long-term prescribing -- Specific strategies for amphetamine and cocaine users -- Specific strategies for cannabis smokers -- 15. International drug policy : is it working? -- How are drugs controlled? -- Strategies aimed at reducing smoking -- Strategies aimed at reducing drinking -- Current policy approaches to illegal drugs -- The war on drugs -- Two invited appraisals of present and future US drug policy / Robert L. DuPont, Ethan Nadelmann -- UK drug policy: is a more radical approach needed? |
| Beschreibung: | 1 Online-Ressource (xviii, 260 p.) |
| ISBN: | 0191575747 0199559961 9780191575747 9780199559961 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043169240 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2009 |||| o||u| ||||||eng d | ||
| 020 | |a 0191575747 |c electronic bk. |9 0-19-157574-7 | ||
| 020 | |a 0199559961 |9 0-19-955996-1 | ||
| 020 | |a 9780191575747 |c electronic bk. |9 978-0-19-157574-7 | ||
| 020 | |a 9780199559961 |9 978-0-19-955996-1 | ||
| 035 | |a (OCoLC)801405724 | ||
| 035 | |a (DE-599)BVBBV043169240 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 362.29 |2 22 | |
| 100 | 1 | |a Robson, Philip |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Forbidden Drugs 3E |c Philip Robson |
| 246 | 1 | 3 | |a Forbidden Drugs 3rd edition |
| 246 | 1 | 3 | |a Forbidden Drugs Third edition |
| 246 | 1 | 3 | |a Forbidden Drugs |
| 250 | |a 3rd ed | ||
| 264 | 1 | |a Oxford |b Oxford University Press |c c2009 | |
| 300 | |a 1 Online-Ressource (xviii, 260 p.) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 500 | |a 1. Why use drugs? -- 2. The consequences of drug use -- 3. Alcohol -- 4. Tobacco -- 5. Cannabis -- 6. Cocaine amphetamines, and other stimulants -- 7. Psychedelics and hallucinogens -- 8. The inhalants -- 9. Ecstasy and other 'party drugs' -- 10. Anabolic steroids -- 11. Tranquillizers and sleeping pills -- 12. Heroin and the opioids -- 13. The nature of addiction -- 14. Helping problem drug users -- 15. International drug policy : is it working? | ||
| 500 | |a 1. Why use drugs? -- The search for 'altered consciousness' -- Practical reasons for experimenting with drugs -- Biological explanations -- Psychological explanations -- Family and cultural explanations -- Risk taking -- Is experimenting with drugs 'abnormal'? -- | ||
| 500 | |a 2. The consequences of drug use -- 'Visible' and 'invisible' drug users -- Short-term consequences -- Longer-term consequences -- Influences upon the outcome of dependent drug use -- | ||
| 500 | |a 3. Alcohol -- Historical background -- Preparation and distribution -- Scientific information -- Possible beneficial effects -- Recreational use -- Unwanted effects -- Acute effects -- Chronic effects -- | ||
| 500 | |a 4. Tobacco -- Preparation and distribution -- Scientific information -- Possible beneficial effects -- Recreational use -- Unwanted effects -- | ||
| 500 | |a 5. Cannabis -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- | ||
| 500 | |a 6. Cocaine amphetamines, and other stimulants -- Cocaine -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Amphetamines -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Other stimulants -- Khat (or Qat) -- Benzylpiperazine -- Pemoline -- Appetite suppressants -- | ||
| 500 | |a 7. Psychedelics and hallucinogens -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Modern ritualistic use -- Recreational use -- Unwanted effects -- | ||
| 500 | |a 8. The inhalants -- Historical background -- Preparations available -- Scientific information -- Recreational use -- Unwanted effects -- | ||
| 500 | |a 9. Ecstasy and other 'party drugs' -- Ecstasy -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Gammahydroxybutyrate (GHB) -- Gamm-butyrolactone (GBL) and 1,4- butanediol (1,4-BD) -- Ketamine -- mCPP -- | ||
| 500 | |a 10. Anabolic steroids -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- | ||
| 500 | |a 11. Tranquillizers and sleeping pills -- Barbiturates -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Benzodiazepines -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- | ||
| 500 | |a 12. Heroin and the opioids -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- | ||
| 500 | |a 13. The nature of addiction -- Introduction -- Neurobiological mechanisms -- Psychological processes -- Socio-cultural influences -- Issues of personal morality -- Conclusion -- | ||
| 500 | |a 14. Helping problem drug users -- Drugs and young people -- Psychological treatments : general principles -- Relapse, prevention and rehabilitation -- Self-help groups -- Specific strategies for smokers -- Specific strategies for drinkers -- Specific strategies for opioid users -- Detoxification -- Substitute or long-term prescribing -- Specific strategies for amphetamine and cocaine users -- Specific strategies for cannabis smokers -- | ||
| 500 | |a 15. International drug policy : is it working? -- How are drugs controlled? -- Strategies aimed at reducing smoking -- Strategies aimed at reducing drinking -- Current policy approaches to illegal drugs -- The war on drugs -- Two invited appraisals of present and future US drug policy / Robert L. DuPont, Ethan Nadelmann -- UK drug policy: is a more radical approach needed? | ||
| 650 | 7 | |a Drogenmissbrauch |2 swd | |
| 650 | 7 | |a Psychopharmakon |2 swd | |
| 650 | 7 | |a PSYCHOLOGY / Psychopathology / Addiction |2 bisacsh | |
| 650 | 7 | |a SELF-HELP / Substance Abuse & Addictions / General |2 bisacsh | |
| 650 | 7 | |a Psychotropic drugs |2 fast | |
| 650 | 7 | |a Substance abuse |2 fast | |
| 650 | 4 | |a Substance-Related Disorders | |
| 650 | 4 | |a Street Drugs | |
| 650 | 4 | |a Substance-Related Disorders / etiology | |
| 650 | 4 | |a Substance abuse |v Popular works | |
| 650 | 4 | |a Psychotropic drugs |v Popular works | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=467539 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028593431 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=467539 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=467539 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175647697797120 |
|---|---|
| any_adam_object | |
| author | Robson, Philip |
| author_facet | Robson, Philip |
| author_role | aut |
| author_sort | Robson, Philip |
| author_variant | p r pr |
| building | Verbundindex |
| bvnumber | BV043169240 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)801405724 (DE-599)BVBBV043169240 |
| dewey-full | 362.29 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 362 - Social problems and services to groups |
| dewey-raw | 362.29 |
| dewey-search | 362.29 |
| dewey-sort | 3362.29 |
| dewey-tens | 360 - Social problems and services; associations |
| discipline | Soziologie |
| edition | 3rd ed |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>06543nmm a2200733zc 4500</leader><controlfield tag="001">BV043169240</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2009 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0191575747</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-19-157574-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0199559961</subfield><subfield code="9">0-19-955996-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780191575747</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-19-157574-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780199559961</subfield><subfield code="9">978-0-19-955996-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)801405724</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043169240</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">362.29</subfield><subfield code="2">22</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Robson, Philip</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Forbidden Drugs 3E</subfield><subfield code="c">Philip Robson</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Forbidden Drugs 3rd edition</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Forbidden Drugs Third edition</subfield></datafield><datafield tag="246" ind1="1" ind2="3"><subfield code="a">Forbidden Drugs</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">3rd ed</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Oxford University Press</subfield><subfield code="c">c2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (xviii, 260 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">1. Why use drugs? -- 2. The consequences of drug use -- 3. Alcohol -- 4. Tobacco -- 5. Cannabis -- 6. Cocaine amphetamines, and other stimulants -- 7. Psychedelics and hallucinogens -- 8. The inhalants -- 9. Ecstasy and other 'party drugs' -- 10. Anabolic steroids -- 11. Tranquillizers and sleeping pills -- 12. Heroin and the opioids -- 13. The nature of addiction -- 14. Helping problem drug users -- 15. International drug policy : is it working?</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">1. Why use drugs? -- The search for 'altered consciousness' -- Practical reasons for experimenting with drugs -- Biological explanations -- Psychological explanations -- Family and cultural explanations -- Risk taking -- Is experimenting with drugs 'abnormal'? --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">2. The consequences of drug use -- 'Visible' and 'invisible' drug users -- Short-term consequences -- Longer-term consequences -- Influences upon the outcome of dependent drug use --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">3. Alcohol -- Historical background -- Preparation and distribution -- Scientific information -- Possible beneficial effects -- Recreational use -- Unwanted effects -- Acute effects -- Chronic effects --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">4. Tobacco -- Preparation and distribution -- Scientific information -- Possible beneficial effects -- Recreational use -- Unwanted effects --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">5. Cannabis -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">6. Cocaine amphetamines, and other stimulants -- Cocaine -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Amphetamines -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Other stimulants -- Khat (or Qat) -- Benzylpiperazine -- Pemoline -- Appetite suppressants --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">7. Psychedelics and hallucinogens -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Modern ritualistic use -- Recreational use -- Unwanted effects --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">8. The inhalants -- Historical background -- Preparations available -- Scientific information -- Recreational use -- Unwanted effects --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">9. Ecstasy and other 'party drugs' -- Ecstasy -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Gammahydroxybutyrate (GHB) -- Gamm-butyrolactone (GBL) and 1,4- butanediol (1,4-BD) -- Ketamine -- mCPP --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">10. Anabolic steroids -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">11. Tranquillizers and sleeping pills -- Barbiturates -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Benzodiazepines -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">12. Heroin and the opioids -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">13. The nature of addiction -- Introduction -- Neurobiological mechanisms -- Psychological processes -- Socio-cultural influences -- Issues of personal morality -- Conclusion --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">14. Helping problem drug users -- Drugs and young people -- Psychological treatments : general principles -- Relapse, prevention and rehabilitation -- Self-help groups -- Specific strategies for smokers -- Specific strategies for drinkers -- Specific strategies for opioid users -- Detoxification -- Substitute or long-term prescribing -- Specific strategies for amphetamine and cocaine users -- Specific strategies for cannabis smokers --</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">15. International drug policy : is it working? -- How are drugs controlled? -- Strategies aimed at reducing smoking -- Strategies aimed at reducing drinking -- Current policy approaches to illegal drugs -- The war on drugs -- Two invited appraisals of present and future US drug policy / Robert L. DuPont, Ethan Nadelmann -- UK drug policy: is a more radical approach needed?</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drogenmissbrauch</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychopharmakon</subfield><subfield code="2">swd</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PSYCHOLOGY / Psychopathology / Addiction</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SELF-HELP / Substance Abuse & Addictions / General</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Psychotropic drugs</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Substance abuse</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance-Related Disorders</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Street Drugs</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance-Related Disorders / etiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Substance abuse</subfield><subfield code="v">Popular works</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Psychotropic drugs</subfield><subfield code="v">Popular works</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=467539</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028593431</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=467539</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=467539</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043169240 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:19:37Z |
| institution | BVB |
| isbn | 0191575747 0199559961 9780191575747 9780199559961 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028593431 |
| oclc_num | 801405724 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (xviii, 260 p.) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | Oxford University Press |
| record_format | marc |
| spelling | Robson, Philip Verfasser aut Forbidden Drugs 3E Philip Robson Forbidden Drugs 3rd edition Forbidden Drugs Third edition Forbidden Drugs 3rd ed Oxford Oxford University Press c2009 1 Online-Ressource (xviii, 260 p.) txt rdacontent c rdamedia cr rdacarrier Includes bibliographical references and index 1. Why use drugs? -- 2. The consequences of drug use -- 3. Alcohol -- 4. Tobacco -- 5. Cannabis -- 6. Cocaine amphetamines, and other stimulants -- 7. Psychedelics and hallucinogens -- 8. The inhalants -- 9. Ecstasy and other 'party drugs' -- 10. Anabolic steroids -- 11. Tranquillizers and sleeping pills -- 12. Heroin and the opioids -- 13. The nature of addiction -- 14. Helping problem drug users -- 15. International drug policy : is it working? 1. Why use drugs? -- The search for 'altered consciousness' -- Practical reasons for experimenting with drugs -- Biological explanations -- Psychological explanations -- Family and cultural explanations -- Risk taking -- Is experimenting with drugs 'abnormal'? -- 2. The consequences of drug use -- 'Visible' and 'invisible' drug users -- Short-term consequences -- Longer-term consequences -- Influences upon the outcome of dependent drug use -- 3. Alcohol -- Historical background -- Preparation and distribution -- Scientific information -- Possible beneficial effects -- Recreational use -- Unwanted effects -- Acute effects -- Chronic effects -- 4. Tobacco -- Preparation and distribution -- Scientific information -- Possible beneficial effects -- Recreational use -- Unwanted effects -- 5. Cannabis -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- 6. Cocaine amphetamines, and other stimulants -- Cocaine -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Amphetamines -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Other stimulants -- Khat (or Qat) -- Benzylpiperazine -- Pemoline -- Appetite suppressants -- 7. Psychedelics and hallucinogens -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Modern ritualistic use -- Recreational use -- Unwanted effects -- 8. The inhalants -- Historical background -- Preparations available -- Scientific information -- Recreational use -- Unwanted effects -- 9. Ecstasy and other 'party drugs' -- Ecstasy -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Gammahydroxybutyrate (GHB) -- Gamm-butyrolactone (GBL) and 1,4- butanediol (1,4-BD) -- Ketamine -- mCPP -- 10. Anabolic steroids -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- 11. Tranquillizers and sleeping pills -- Barbiturates -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- Benzodiazepines -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- 12. Heroin and the opioids -- Historical background -- Preparation and distribution -- Scientific information -- Medical uses -- Recreational use -- Unwanted effects -- 13. The nature of addiction -- Introduction -- Neurobiological mechanisms -- Psychological processes -- Socio-cultural influences -- Issues of personal morality -- Conclusion -- 14. Helping problem drug users -- Drugs and young people -- Psychological treatments : general principles -- Relapse, prevention and rehabilitation -- Self-help groups -- Specific strategies for smokers -- Specific strategies for drinkers -- Specific strategies for opioid users -- Detoxification -- Substitute or long-term prescribing -- Specific strategies for amphetamine and cocaine users -- Specific strategies for cannabis smokers -- 15. International drug policy : is it working? -- How are drugs controlled? -- Strategies aimed at reducing smoking -- Strategies aimed at reducing drinking -- Current policy approaches to illegal drugs -- The war on drugs -- Two invited appraisals of present and future US drug policy / Robert L. DuPont, Ethan Nadelmann -- UK drug policy: is a more radical approach needed? Drogenmissbrauch swd Psychopharmakon swd PSYCHOLOGY / Psychopathology / Addiction bisacsh SELF-HELP / Substance Abuse & Addictions / General bisacsh Psychotropic drugs fast Substance abuse fast Substance-Related Disorders Street Drugs Substance-Related Disorders / etiology Substance abuse Popular works Psychotropic drugs Popular works http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=467539 Aggregator Volltext |
| spellingShingle | Robson, Philip Forbidden Drugs 3E Drogenmissbrauch swd Psychopharmakon swd PSYCHOLOGY / Psychopathology / Addiction bisacsh SELF-HELP / Substance Abuse & Addictions / General bisacsh Psychotropic drugs fast Substance abuse fast Substance-Related Disorders Street Drugs Substance-Related Disorders / etiology Substance abuse Popular works Psychotropic drugs Popular works |
| title | Forbidden Drugs 3E |
| title_alt | Forbidden Drugs 3rd edition Forbidden Drugs Third edition Forbidden Drugs |
| title_auth | Forbidden Drugs 3E |
| title_exact_search | Forbidden Drugs 3E |
| title_full | Forbidden Drugs 3E Philip Robson |
| title_fullStr | Forbidden Drugs 3E Philip Robson |
| title_full_unstemmed | Forbidden Drugs 3E Philip Robson |
| title_short | Forbidden Drugs 3E |
| title_sort | forbidden drugs 3e |
| topic | Drogenmissbrauch swd Psychopharmakon swd PSYCHOLOGY / Psychopathology / Addiction bisacsh SELF-HELP / Substance Abuse & Addictions / General bisacsh Psychotropic drugs fast Substance abuse fast Substance-Related Disorders Street Drugs Substance-Related Disorders / etiology Substance abuse Popular works Psychotropic drugs Popular works |
| topic_facet | Drogenmissbrauch Psychopharmakon PSYCHOLOGY / Psychopathology / Addiction SELF-HELP / Substance Abuse & Addictions / General Psychotropic drugs Substance abuse Substance-Related Disorders Street Drugs Substance-Related Disorders / etiology Substance abuse Popular works Psychotropic drugs Popular works |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=467539 |
| work_keys_str_mv | AT robsonphilip forbiddendrugs3e AT robsonphilip forbiddendrugs3rdedition AT robsonphilip forbiddendrugsthirdedition AT robsonphilip forbiddendrugs |